EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 32020R1003

Commission Implementing Regulation (EU) 2020/1003 of 9 July 2020 renewing the approval of the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 as low-risk substances in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

C/2020/4543

OJ L 221, 10.7.2020, p. 127–132 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

In force

ELI: http://data.europa.eu/eli/reg_impl/2020/1003/oj

10.7.2020   

EN

Official Journal of the European Union

L 221/127


COMMISSION IMPLEMENTING REGULATION (EU) 2020/1003

of 9 July 2020

renewing the approval of the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 as low-risk substances in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011

(Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1107/2009, of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC (1), and in particular Article 20(1) thereof,

Whereas:

(1)

Commission Directive 2008/113/EC (2) included Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 as active substances in Annex I to Council Directive 91/414/EEC (3).

(2)

Active substances included in Annex I to Directive 91/414/EEC are deemed to have been approved under Regulation (EC) No 1107/2009 and are listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 (4).

(3)

The approval of the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011 expires on 30 April 2021.

(4)

An application for the renewal of the approval of the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 (5) within the time period provided for in that Article.

(5)

The applicant submitted the supplementary dossiers required in accordance with Article 6 of Implementing Regulation (EU) No 844/2012. The application was found to be complete by the rapporteur Member State.

(6)

The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on 28 September 2018.

(7)

The Authority made the supplementary summary dossier available to the public. The Authority also circulated the renewal assessment report to the applicants and to the Member States for comments and launched a public consultation on it. The Authority forwarded the comments received to the Commission.

(8)

On 18 September 2019, the Authority communicated to the Commission its conclusion (6) on whether Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009. The Commission presented an initial renewal report and the draft Regulation regarding Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 to the Standing Committee on Plants, Animals, Food and Feed in March 2020.

(9)

The Commission invited the applicant to submit its comments on the conclusion of the Authority and, in accordance with the third paragraph of Article 14(1) of Implementing Regulation (EU) No 844/2012, on the renewal report. The applicant submitted its comments, which have been carefully examined.

(10)

It has been established with respect to one or more representative uses of at least one plant protection product containing the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 or FOC PG 410.3 that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.

(11)

The risk assessment for the renewal of the approval of the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing Phlebiopsis gigantea strains VRA 1835, VRA 1984 or FOC PG 410.3 may be authorised. It is therefore appropriate not to maintain the restriction to use as a fungicide only.

(12)

The Commission further considers that Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 are low-risk active substances pursuant to Article 22 of Regulation (EC) No 1107/2009. Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 are not substances of concern and fulfil the conditions set in Annex II point 5 to Regulation (EC) No 1107/2009. Following the assessment by the Rapporteur Member State and the Authority, and taking into account the intended uses, Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 are microorganisms for which it is expected a low-risk for humans, animals and the environment. No critical areas of concern were identified, and Phlebiopsis gigantea is not known to be related to any human or animal pathogen. Phlebiopsis gigantea has been used as a biocontrol agent for over a decade without leading to any adverse effect on humans since the previous peer review, and based on the intended use (i.e. direct application onto stump surface of coniferous trees) the potential exposure for humans and effects on the naturally occurring soil-concentration are considered negligible. For these reasons only general mitigation measures are foreseen for workers, and overall the approval criteria and qualification as low-risk are met for these active substances.

(13)

It is therefore appropriate to renew the approval of Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 as low-risk substances.

(14)

In accordance with Article 20(3) of Regulation (EC) No 1107/2009, in conjunction with Article 13(4) thereof, the Annex to Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(15)

Commission Implementing Regulation (EU) 2020/421 (7) extended the approval period of Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3 to 30 April 2021 in order to allow the renewal process to be completed before the expiry of the approval period of those active substances. Given that a decision on renewal is being taken ahead of the expiry of that extended approval period, this Regulation should apply from 1 September 2020.

(16)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS REGULATION:

Article 1

Renewal of the approval of the active substance

The approval of the active substances Phlebiopsis gigantea strains VRA 1835, VRA 1984 and FOC PG 410.3, as specified in Annex I, is renewed subject to the conditions laid down in that Annex.

Article 2

Amendments to Implementing Regulation (EU) No 540/2011

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.

Article 3

Entry into force and date of application

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

It shall apply from 1 September 2020.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 9 July 2020.

For the Commission

The President

Ursula VON DER LEYEN


(1)  OJ L 309, 24.11.2009, p. 1.

(2)  Commission Directive 2008/113/EC of 8 December 2008 amending Council Directive 91/414/EEC to include several micro-organisms as active substances (OJ L 330, 9.12.2008, p. 6).

(3)  Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230, 19.8.1991, p. 1).

(4)  Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (OJ L 153, 11.6.2011, p. 1).

(5)  Commission Implementing Regulation (EU) No 844/2012 of 18 September 2012 setting out the provisions necessary for the implementation of the renewal procedure for active substances, as provided for in Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (OJ L 252, 19.9.2012, p. 26).

(6)  EFSA Journal 17(10):5820, doi: 10.2903/j.efsa.2019.5820. Available online: www.efsa.europa.eu

(7)  Commission Implementing Regulation (EU) 2020/421 of 18 March 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances abamectin, Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, clopyralid, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, Lecanicillium muscarium (formerly ‘Verticillium lecani i’) strain Ve6, mepanipyrim, Metarhizium anisopliae (var. anisopliae) strain BIPESCO 5/F52, metconazole, metrafenone, Phlebiopsis gigantea strains FOC PG 410.3, VRA 1835 and VRA 1984, pirimicarb, Pseudomonas chlororaphis strain MA342, pyrimethanil, Pythium oligandrum M1, rimsulfuron, spinosad, Streptomyces K61 (formerly ‘S. griseoviridi s’), Trichoderma asperellum (formerly ‘T. harzianu m’) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly ‘T. harzianu m’) strains IMI 206040 and T11, Trichoderma gamsii (formerly ‘T. virid e’) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (OJ L 84, 20.3.2020, p. 7).


ANNEX I

Common Name,

Identification Numbers

IUPAC Name

Purity (1)

Date of approval

Expiration of approval

Specific provisions

Phlebiopsis gigantea strain VRA 1835

Not applicable

No relevant impurities

1 September 2020

31 August 2035

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Phlebiopsis gigantea strain VRA 1835, and in particular Appendices I and II thereto, shall be taken into account.

Member States shall pay particular attention to the protection of operators and workers.

Producers shall ensure strict maintenance of environmental conditions and quality control analysis during the manufacturing process as laid down in Working Document SANCO/12116/2012 as regards the limits on microbiological contamination (2).

Phlebiopsis gigantea strain VRA 1984

Not applicable

No relevant impurities

1 September 2020

31 August 2035

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Phlebiopsis gigantea strain VRA 1984, and in particular Appendices I and II thereto, shall be taken into account.

Member States shall pay particular attention to the protection of operators and workers.

Producers shall ensure strict maintenance of environmental conditions and quality control analysis during the manufacturing process as laid down in Working Document SANCO/12116/2012 as regards the limits on microbiological contamination.

Phlebiopsis gigantea strain FOC PG 410.3

Not applicable

No relevant impurities

1 September 2020

31 August 2035

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Phlebiopsis gigantea strain FOC PG 410.3, and in particular Appendices I and II thereto, shall be taken into account.

Member States shall pay particular attention to the protection of operators and workers.

Producers shall ensure strict maintenance of environmental conditions and quality control analysis during the manufacturing process as laid down in Working Document SANCO/12116/2012 as regards the limits on microbiological contamination.


(1)  Further details on the identity and the specification of the active substance are provided in the renewal report.

(2)  https://ec.europa.eu/food/sites/food/files/plant/docs/pesticides_ppp_app-proc_guide_phys-chem-ana_microbial-contaminant-limits.pdf


ANNEX II

The Annex to Commission Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in Part A, entry 201 on Phlebiopsis gigantea strains is replaced as follows:

‘201

Phlebiopsis gigantea

STRAIN: VRA 1985

Culture collection: No DSM 16202

STRAIN: VRA 1986

Culture collection: No DSM 16203

STRAIN: FOC PG B20/5

Culture collection: No IMI 390096

STRAIN: FOC PG SP log 6

Culture collection: No IMI 390097

STRAIN: FOC PG SP log 5

Culture collection: No IMI 390098

STRAIN: FOC PG BU 3

Culture collection: No IMI 390099

STRAIN: FOC PG BU 4

Culture collection: No IMI 390100

STRAIN: FOC PG97/1062/116/1.1

Culture collection: No IMI 390102

STRAIN: FOC PG B22/SP1287/3.1

Culture collection: No IMI 390103

STRAIN: FOC PG SH 1

Culture collection: No IMI 390104

STRAIN: FOC PG B22/SP1190/3.2

Culture collection: No IMI 390105

Not applicable

No relevant impurities

1 May 2009

30 April 2020

PART A Only uses as fungicide may be authorised.

PART B For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on Phlebiopsis gigantea (SANCO/1863/2008) and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health shall be taken into account. Conditions of use shall include, where appropriate, risk mitigation measures.’

(2)

in Part D, the following entries are added:

‘21

Phlebiopsis gigantea strain VRA 1835

Not applicable

No relevant impurities

1 September 2020

31 August 2035

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Phlebiopsis gigantea strain VRA 1835, and in particular Appendices I and II thereto, shall be taken into account.

Member States shall pay particular attention to the protection of operators and workers.

Producers shall ensure strict maintenance of environmental conditions and quality control analysis during the manufacturing process as laid down in Working Document SANCO/12116/2012 as regards the limits on microbiological contamination.

22

Phlebiopsis gigantea strain VRA 1984

Not applicable

No relevant impurities

1 September 2020

31 August 2035

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Phlebiopsis gigantea strain VRA 1984, and in particular Appendices I and II thereto, shall be taken into account.

Member States shall pay particular attention to the protection of operators and workers.

Producers shall ensure strict maintenance of environmental conditions and quality control analysis during the manufacturing process as laid down in Working Document SANCO/12116/2012 as regards the limits on microbiological contamination.

23

Phlebiopsis gigantea strain FOC PG 410.3

Not applicable

No relevant impurities

1 September 2020

31 August 2035

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Phlebiopsis gigantea strain FOC PG 410.3, and in particular Appendices I and II thereto, shall be taken into account.

Member States shall pay particular attention to the protection of operators and workers.

Producers shall ensure strict maintenance of environmental conditions and quality control analysis during the manufacturing process as laid down in Working Document SANCO/12116/2012 as regards the limits on microbiological contamination.’


Top